Minerva Neurosciences, Inc. Operating Expenses
Minerva Neurosciences, Inc. (NERV) reported Operating Expenses of $10.64 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-07
- Minerva Neurosciences, Inc. operating expenses for the quarter ending 2026-06-30 was $10.64M, a 215.40% increase year-over-year.
- Minerva Neurosciences, Inc. operating expenses for the quarter ending 2026-03-31 was $16.67M, a 327.16% increase year-over-year.
- Minerva Neurosciences, Inc. operating expenses for the quarter ending 2025-12-31 was $4.98M, a 10.16% increase year-over-year.
- Minerva Neurosciences, Inc. operating expenses for the quarter ending 2025-09-30 was $2.84M, a 34.86% decline year-over-year.
- Minerva Neurosciences, Inc. operating expenses for fiscal 2025 was $15.10M, a 30.87% decline from fiscal 2024.
- Minerva Neurosciences, Inc. operating expenses for fiscal 2024 was $21.85M, a 5.50% decline from fiscal 2023.
- Minerva Neurosciences, Inc. operating expenses for fiscal 2023 was $23.12M, a 8.37% decline from fiscal 2022.
- Minerva Neurosciences, Inc. operating expenses for fiscal 2022 was $25.23M, a 44.38% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.64M 10-Q · filed 2026-08-07 | $27.31M 10-Q · filed 2026-08-07 | $32.30M derived: sum of 3 quarters · filed 2026-08-07 | $35.14M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $16.67M 10-Q · filed 2026-05-05 | $21.65M derived: sum of 2 quarters · filed 2026-05-05 | $24.50M derived: sum of 3 quarters · filed 2026-05-05 | $27.87M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $4.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $7.83M derived: sum of 2 quarters · filed 2026-03-11 | $11.20M derived: sum of 3 quarters · filed 2026-08-07 | $15.10M 10-K · filed 2026-03-11 |
| 2025-09-30 | $2.84M 10-Q · filed 2025-11-05 | $6.22M derived: sum of 2 quarters · filed 2026-08-07 | $10.12M 10-Q · filed 2025-11-05 | $14.64M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $3.37M 10-Q · filed 2026-08-07 | $7.28M 10-Q · filed 2026-08-07 | $11.80M derived: sum of 3 quarters · filed 2026-08-07 | $16.17M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $3.90M 10-Q · filed 2026-05-05 | $8.43M derived: sum of 2 quarters · filed 2026-05-05 | $12.79M derived: sum of 3 quarters · filed 2026-05-05 | $19.07M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $4.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $8.89M derived: sum of 2 quarters · filed 2026-03-11 | $15.17M derived: sum of 3 quarters · filed 2026-03-11 | $21.85M 10-K · filed 2026-03-11 |
| 2024-09-30 | $4.37M 10-Q · filed 2025-11-05 | $10.64M derived: sum of 2 quarters · filed 2025-11-05 | $17.33M 10-Q · filed 2025-11-05 | $24.50M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $6.28M 10-Q · filed 2025-08-14 | $12.96M 10-Q · filed 2025-08-14 | $20.13M derived: sum of 3 quarters · filed 2025-08-14 | $26.21M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $6.68M 10-Q · filed 2025-05-13 | $13.85M derived: sum of 2 quarters · filed 2025-05-13 | $19.93M derived: sum of 3 quarters · filed 2025-05-13 | $24.45M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $7.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $13.25M derived: sum of 2 quarters · filed 2025-02-25 | $17.77M derived: sum of 3 quarters · filed 2025-02-25 | $23.12M 10-K · filed 2025-02-25 |
| 2023-09-30 | $6.08M 10-Q · filed 2024-11-05 | $10.60M derived: sum of 2 quarters · filed 2024-11-05 | $15.95M 10-Q · filed 2024-11-05 | $21.02M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $4.52M 10-Q · filed 2024-08-06 | $9.87M 10-Q · filed 2024-08-06 | $14.94M derived: sum of 3 quarters · filed 2024-08-06 | $20.15M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $5.35M 10-Q · filed 2024-05-01 | $10.42M derived: sum of 2 quarters · filed 2024-05-01 | $15.63M derived: sum of 3 quarters · filed 2024-05-01 | $22.59M derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | $5.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $10.28M derived: sum of 2 quarters · filed 2024-02-22 | $17.24M derived: sum of 3 quarters · filed 2024-02-22 | $25.23M 10-K · filed 2024-02-22 |
| 2022-09-30 | $5.21M 10-Q · filed 2023-11-07 | $12.17M derived: sum of 2 quarters · filed 2023-11-07 | $20.16M 10-Q · filed 2023-11-07 | $41.54M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $6.97M 10-Q · filed 2023-08-01 | $14.95M 10-Q · filed 2023-08-01 | $36.33M derived: sum of 3 quarters · filed 2023-08-01 | $43.85M derived: sum of 4 quarters · filed 2023-08-01 |
| 2022-03-31 | $7.99M 10-Q · filed 2023-05-15 | $29.37M derived: sum of 2 quarters · filed 2023-05-15 | $36.88M derived: sum of 3 quarters · filed 2023-05-15 | $45.85M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $21.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $28.89M derived: sum of 2 quarters · filed 2023-03-08 | $37.86M derived: sum of 3 quarters · filed 2023-03-08 | $45.37M 10-K · filed 2023-03-08 |
| 2021-09-30 | $7.52M 10-Q · filed 2022-11-09 | $16.48M derived: sum of 2 quarters · filed 2022-11-09 | $23.99M 10-Q · filed 2022-11-09 | $31.29M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $8.96M 10-Q · filed 2022-08-09 | $16.47M 10-Q · filed 2022-08-09 | $23.77M derived: sum of 3 quarters · filed 2022-08-09 | $31.86M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $7.51M 10-Q · filed 2022-05-04 | $14.81M derived: sum of 2 quarters · filed 2022-05-04 | $22.90M derived: sum of 3 quarters · filed 2022-05-04 | $34.56M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $7.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $15.39M derived: sum of 2 quarters · filed 2022-03-01 | $27.06M derived: sum of 3 quarters · filed 2022-03-01 | $39.33M 10-K · filed 2022-03-01 |
| 2020-09-30 | $8.09M 10-Q · filed 2021-11-08 | $19.76M derived: sum of 2 quarters · filed 2021-11-08 | $32.03M 10-Q · filed 2021-11-08 | $64.40M derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $11.67M 10-Q · filed 2021-08-02 | $23.94M 10-Q · filed 2021-08-02 | $56.31M derived: sum of 3 quarters · filed 2021-08-02 | $70.59M derived: sum of 4 quarters · filed 2021-08-02 |
| 2020-03-31 | $12.27M 10-Q · filed 2021-05-12 | $44.64M derived: sum of 2 quarters · filed 2021-05-12 | $58.92M derived: sum of 3 quarters · filed 2021-05-12 | $71.82M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $32.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $46.65M derived: sum of 2 quarters · filed 2021-03-08 | $59.55M derived: sum of 3 quarters · filed 2021-03-08 | $75.87M 10-K · filed 2021-03-08 |
| 2019-09-30 | $14.28M 10-Q · filed 2020-11-02 | $27.19M derived: sum of 2 quarters · filed 2020-11-02 | $43.50M 10-Q · filed 2020-11-02 | $57.13M derived: sum of 4 quarters · filed 2020-11-02 |
| 2019-06-30 | $12.90M 10-Q · filed 2020-08-03 | $29.22M 10-Q · filed 2020-08-03 | $42.84M derived: sum of 3 quarters · filed 2020-08-03 | $55.27M derived: sum of 4 quarters · filed 2020-08-03 |
| 2019-03-31 | $16.31M 10-Q · filed 2020-05-04 | $29.94M derived: sum of 2 quarters · filed 2020-05-04 | $42.36M derived: sum of 3 quarters · filed 2020-05-04 | $55.30M derived: sum of 4 quarters · filed 2020-05-04 |
| 2018-12-31 | $13.63M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $26.05M derived: sum of 2 quarters · filed 2020-03-09 | $38.99M derived: sum of 3 quarters · filed 2020-03-09 | $51.73M 10-K · filed 2020-03-09 |
| 2018-09-30 | $12.42M 10-Q · filed 2019-11-04 | $25.36M derived: sum of 2 quarters · filed 2019-11-04 | $38.10M 10-Q · filed 2019-11-04 | $47.63M derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | $12.93M 10-Q · filed 2019-08-05 | $25.68M 10-Q · filed 2019-08-05 | $35.21M derived: sum of 3 quarters · filed 2019-08-05 | $46.62M derived: sum of 4 quarters · filed 2019-08-05 |
| 2018-03-31 | $12.74M 10-Q · filed 2019-05-06 | $22.28M derived: sum of 2 quarters · filed 2019-05-06 | $33.68M derived: sum of 3 quarters · filed 2019-05-06 | $43.43M derived: sum of 4 quarters · filed 2019-05-06 |
| 2017-12-31 | $9.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $20.94M derived: sum of 2 quarters · filed 2019-03-12 | $30.69M derived: sum of 3 quarters · filed 2019-03-12 | $41.17M 10-K · filed 2019-03-12 |
| 2017-09-30 | $11.41M 10-Q · filed 2018-11-05 | $21.15M derived: sum of 2 quarters · filed 2018-11-05 | $31.64M 10-Q · filed 2018-11-05 | $40.88M derived: sum of 4 quarters · filed 2018-11-05 |
| 2017-06-30 | $9.75M 10-Q · filed 2018-08-02 | $20.23M 10-Q · filed 2018-08-02 | $29.47M derived: sum of 3 quarters · filed 2018-08-02 | $37.70M derived: sum of 4 quarters · filed 2018-08-02 |
| 2017-03-31 | $10.49M 10-Q · filed 2018-05-03 | $19.72M derived: sum of 2 quarters · filed 2018-05-03 | $27.95M derived: sum of 3 quarters · filed 2018-05-03 | $32.92M derived: sum of 4 quarters · filed 2018-05-03 |
| 2016-12-31 | $9.24M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $17.47M derived: sum of 2 quarters · filed 2018-03-12 | $22.43M derived: sum of 3 quarters · filed 2018-03-12 | $30.19M 10-K · filed 2018-03-12 |
| 2016-09-30 | $8.23M 10-Q · filed 2017-11-06 | $13.20M derived: sum of 2 quarters · filed 2017-11-06 | $20.95M 10-Q · filed 2017-11-06 | $29.15M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $4.96M 10-Q · filed 2017-08-03 | $12.72M 10-Q · filed 2017-08-03 | $20.92M derived: sum of 3 quarters · filed 2018-03-12 | $26.62M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $7.76M 10-Q · filed 2017-05-04 | $15.95M derived: sum of 2 quarters · filed 2018-03-12 | $21.66M derived: sum of 3 quarters · filed 2018-03-12 | $27.99M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $8.19M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $13.90M derived: sum of 2 quarters · filed 2018-03-12 | $20.23M derived: sum of 3 quarters · filed 2018-03-12 | $26.11M 10-K · filed 2018-03-12 |
| 2015-09-30 | $5.70M 10-Q · filed 2016-11-03 | $12.04M derived: sum of 2 quarters · filed 2016-11-03 | $17.92M 10-Q · filed 2016-11-03 | $25.36M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-06-30 | $6.33M 10-Q · filed 2016-08-04 | $12.21M 10-Q · filed 2016-08-04 | $19.66M derived: sum of 3 quarters · filed 2017-03-13 | $46.81M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-03-31 | $5.88M 10-Q · filed 2016-05-03 | $13.32M derived: sum of 2 quarters · filed 2017-03-13 | $40.48M derived: sum of 3 quarters · filed 2017-03-13 | $58.13M derived: sum of 4 quarters · filed 2017-03-13 |
| 2014-12-31 | $7.45M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $34.60M derived: sum of 2 quarters · filed 2017-03-13 | $52.25M derived: sum of 3 quarters · filed 2017-03-13 | $54.87M 10-K · filed 2017-03-13 |
| 2014-09-30 | $27.15M 10-Q · filed 2015-11-05 | $44.80M derived: sum of 2 quarters · filed 2015-11-05 | $47.42M 10-Q · filed 2015-11-05 | $49.47M derived: sum of 4 quarters · filed 2015-11-05 |
| 2014-06-30 | $17.65M 10-Q · filed 2015-08-05 | $20.27M 10-Q · filed 2015-08-05 | $22.32M derived: sum of 3 quarters · filed 2015-08-05 | $22.80M derived: sum of 4 quarters · filed 2015-08-05 |
| 2014-03-31 | $2.62M 10-Q · filed 2015-05-07 | $4.67M derived: sum of 2 quarters · filed 2015-05-07 | $5.15M derived: sum of 3 quarters · filed 2015-05-07 | $5.53M derived: sum of 4 quarters · filed 2015-05-07 |
| 2013-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $2.52M derived: sum of 2 quarters · filed 2015-03-26 | $2.90M derived: sum of 3 quarters · filed 2015-03-26 | $3.17M 10-K · filed 2015-03-26 |
| 2013-09-30 | $482.47K 10-Q · filed 2014-11-06 | $861.26K derived: sum of 2 quarters · filed 2014-11-06 | $1.13M 10-Q · filed 2014-11-06 | |
| 2013-06-30 | $378.79K 10-Q · filed 2014-08-07 | $650.12K 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |